Author: News Room

TORRANCE, Calif., July 25, 2024 (GLOBE NEWSWIRE) —  Navitas Semiconductor (Nasdaq: NVTS), the industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors, today released its 4.5 kW AI data center power supply reference design, with optimized GaNSafe™ and Gen-3 ‘Fast’ (G3F) SiC power components. The optimized design enables the world’s highest power density with 137 W/in3 and over 97% efficiency. Next-generation AI GPUs like NVIDIA’s Blackwell B100 and B200 each demand over 1 kW of power for high-power computation, 3x higher than traditional CPUs. These new demands are driving power-per-rack specifications from 30-40 kW…

NORWALK, Conn. and SINGAPORE, July 25, 2024 (GLOBE NEWSWIRE) — Infinite Reality (iR), an innovation company powering the next generation of digital media and e-commerce through artificial intelligence (AI), spatial computing, extended reality, and other immersive technologies, is proud to announce a strategic collaboration with the Global Esports Federation (GEF), joining such brands as Tencent, Amazon, and MGM Studios as a Global Partner of the GEF. Combining iR’s technology suite and sports media ecosystem including ReKT Global (owners of Rogue and Carolina Royal Ravens), with GEF’s expertise, reach, and relationships within the massive global gaming community of more than 3…

Meets primary study endpoints with pharmacokinetics (PK) comparable whether Anaphylm is administered by subjects or by healthcare providers (HCPs)Final supportive study, the Oral Allergy Syndrome (OAS) challenge study, currently enrolling Continues to anticipate requesting a pre-New Drug Application (NDA) meeting before the end of the third quarter WARREN, N.J., July 25, 2024 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, today released positive topline PK data from the self-administration study of Anaphylm™ (epinephrine) Sublingual Film. Anaphylm has the…

SAN FRANCISCO, July 25, 2024 (GLOBE NEWSWIRE) — During prolonged power outages in the aftermath of Hurricane Beryl, more than 1,600 customers of Sunrun (Nasdaq: RUN), the nation’s leading provider of clean energy as a subscription service, in the greater Houston area were able to keep their homes energized with more than 70,000 hours of backup energy provided by their solar-plus-storage systems. Beryl slammed ashore as a Category 1 storm on July 8, knocking out power to nearly 3 million homes and businesses in Texas. Some residents waited more than a week for grid power to be restored in their…

VANCOUVER, British Columbia, July 25, 2024 (GLOBE NEWSWIRE) — COLLECTIVE METALS INC. (CSE: COMT | OTC: CLLMF | FSE: TO1) (the “Company” or “Collective”) is pleased to announce the successful completion of Phase 1 2024 exploration activities (the “Program”) at the Company’s Princeton Copper Project (the “Project”) in British Columbia, Canada. Highlights 658 soil samples collected over two high-priority copper targets;Additional soil grid completed over newly-recognized geophysical anomaly;Rock sampling and alteration mapping confirm the highly prospective nature of the Project; andIP survey planned for Phase 2 work. Following the Company’s recent review of the Trojan-Condor target area as well as…

VANCOUVER, British Columbia, July 25, 2024 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”) is pleased to announce its first drill results of the 2024 season from its wholly owned Thorn Project located in NW British Columbia, Canada. The 2880 square-kilometer claim group is located within the traditional territory of the Tahltan First Nation and the Taku River Tlingit First Nation. The Thorn Project is an underexplored copper-gold porphyry district with 16 large scale exploration target areas identified. Brixton is currently drilling with two rigs until the end of the season. Ground MT geophysical…

Ottawa, ON, July 25, 2024 (GLOBE NEWSWIRE) — The impressive transformation of the 129,000 square-foot facility at 1660 Carling Street site will soon be the home of Altea Ottawa, with its grand opening set for late 2024. The Ottawa club marks the fourth and largest community launch for Altea, rapidly emerging as one of Canada’s premier fitness and wellness brands. In anticipation of Altea’s grand opening in Ottawa, co-founders David Wu and Mike Nolan, along with Altea’s board of directors, are pleased to announce that long-time board member Jeff York has joined the senior management team as Altea’s CEO, and…

PORT ANGELES, Wash., July 25, 2024 (GLOBE NEWSWIRE) — “In spite of challenging times for the entire industry as a result of the rate environment, First Northwest executed on a balance sheet restructure strategy. The restructure included a sale-leaseback transaction for six of our branches, a restructure of our bank-owned life insurance policies, two securities loss sale transactions, two balance sheet hedges against fixed rate loans and municipal bonds and the sale of our Visa B shares,” commented Matthew P. Deines, President and CEO. “As a result, we reached an inflection point for the net interest margin in the second quarter after declines…

NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) — RiskLayer, the DeFi Economic Security AVS on Eigenlayer, has secured its ‘Builders round’ co-led by Antler and Momentum6 with participation from Wagmi Ventures, Hypotenuse ventures, and notable angels, including Richard Ma (Founder, Zircuit), Ishaan 0x (Strategy, Eigenlayer), Agnish Ghosh (Core, EthNimbus), Alex (Core Contributor, FranklinDAO) and Paul Taylor (Ex-Blackrock) among others. RiskLayer proposes two separate Actively Validates Services (AVSs) on EigenLayer as a solution to key DeFi economic security concerns. Chainrisk Labs, the developers behind RiskLayer, has secured over $10B in assets under management to date, serving protocols like Compound, Angle Labs,…

First-in-Class CCL24 Neutralizing Antibody CM-101 Demonstrated a Favorable Safety Profile and Was Generally Well-Tolerated Demonstrated Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Activity across Multiple Components of Primary Sclerosing Cholangitis (PSC), Establishing Clinical Proof-of-Concept for the Disease-Modifying Potential of CM-101 Treatment with CM-101 Led to Statistically Significant Improvements in Liver Stiffness, a Well-Validated Biomarker of Disease Progression in PSC Treatment with CM-101 Led to Statistically Significant Improvements in Pruritis and Improvements in Total Bilirubin and Liver Function Tests Positive Phase 2 Data Paves Way for End-of-Phase 2 Meeting with U.S. Food and Drug Administration and Preparations for a Phase 3 Trial in PSC Company to…